Stability of poly (ε caprolacton) nanospheres in sterile aqueous media

International Journal of Pharmaceutics

Volumn 139, Issue 1-2, 1996, Pages 113-123

  Masson, V ^a   Maurin, F ^a   Devissaguet, J P ^b   Fessi, H ^c  

^a Laboratoire Chauvin   (France)

^b UNIV PARIS SUD   (France)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

Nanospheres; Poly ( caprolacton); Polymer degradation; Stability

Indexed keywords

CREMOPHOR; HYDROXYETHYLCELLULOSE; NANOPARTICLE; POLOXAMER; POLYCAPROLACTONE; POLYMER; PRESERVATIVE; SURFACTANT; THIOMERSAL;

ARTICLE; DRUG DEGRADATION; DRUG HYDROLYSIS; DRUG STABILITY; MOLECULAR WEIGHT; PARTICLE SIZE; PH; PRIORITY JOURNAL; STORAGE; TEMPERATURE;

EID: 0030576591     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(96)04611-X     Document Type: Article

References (44)

1. Ali, S., Mechanisms of polymer degradation in implantable devices. I. Poly(caprolactone). Biomaterials, 14 (9) (1993) 648-656.
2. Al Khouri, F., Roblot-Treupel, L., Fessi, H., Devissaguet, J.P. and Puisieux, F., Development of a new process for the manufacture of polyisobutylcyanoacrylate nanocapsules. Int. J. Pharm., 28 (1986) 125-132.
3. Ameche, B., Bendix, D. and Entenmann, G., Resorbable polyesters: composition, properties, applications. Clin. Mat., 10 (1992) 47-50.
4. Belbella, A., Contribution à l'étude de la dégradation de vecteurs colloïdaux polymères constitués de poly (D,L-lactide) et de poly (D,L-lactide-co-glycolide). Thesis, Mention Sciences Pharmaceutiques, no. 406, Université de Paris-Sud, France, 1995.
5. Benedict, C., Fungal degradation of polycaprolactones. J. Appl. Polym. Sci., 28 (1983a) 327-334.
6. Benedict, C., Polycaprolactone degradation by mixed and pure cultures of bacteria and a yeast. J. Appl. Polym. Sci., 28 (1983b) 335-342.
7. Bruck, S., Biostability of materials and implants. J. Long Term Eff. Med. Impl., 1 (1) (1991) 89-106.
8. Coffin, M. and McGinity, J., Physical and chemical stability of aqueous colloïdal dispersions of poly (D,L-lactide) and poly (ε caprolactone). In Florence, A.T. and Gregoriadis, G. (Eds), Drug Targeting and Delivery, Vol. 1, Harwood Academic Publishers, New York, 1992a, pp. 197-214.
9. Coffin, M. and McGinity J., Biodegradable pseudolatexes. The chemical stability of poly (D,L-lactide) and poly (ε caprolactone) nanoparticles in aqueous media. Pharm. Res., 9 (2) (1992b) 200-205.
10. Diepold., R., Kreuter, J., Himbert, J., Gurny, R., Lee, V., Robinson, J., Saettone, M. and Schnaudigel, O., Comparison of different models for the testing of pilocarpine eyedrops using conventional eyedrops and a novel depot formulation (nanoparticles). Graefe's Arch. Clin. Exp. Ophthalmol., 227 (1989) 188-193.
11. Fessi, H., Devissaguet, J.P. and Puisieux, F., US Patent No. 5 049 322 (1991).
12. Fessi, H., Devissaguet, J.P., Puisieux, F. and Thies, C., US Patent No. 5 118 528 (1992).
13. Fields R., Rodriguez, F. and Finn, R., Microbial degradation of polyesters: polycaprolactone degraded by P. Pullulans. J. Appl. Polym. Sci., 18 (1974) 3571-3579.
14. Gurny, R., Peppas, N., Harrington, D. and Banker, U., Development of biodegradable and injectable latices for controlled release of potent drugs. Drug Med. Ind. Pharm., 7 (1) (1981) 1-25.
15. Guterres, S.S., Fessi, H., Barratt, G., Devissaguet, J.P. and Puisieux, F., Poly (D,L-lactide) nanocapsules containing diclofenac. I. Formulation and stability study. Int. J. Pharm., 113 (1995) 57-63.
16. Harmia, T., Kreuter, J., Speiser, P., Boye, T., Gurny, R. and Kubis, A., Enhancement of the myotic response of rabbits with pilocarpine loaded polybutylcyanoacrylate particles. Int. J. Pharm., 33 (1986) 187-193.
17. Holland, S., Tighe, B. and Gould, P., Polymers for biodegradable medical devices. 1. The potential of polyesters as controlled macromolecular release systems. J. Controlled Release, 4 (1986) 155-180.
18. Jarrett, P., Benedict, C., Bell, J.P., Cameron, J.A. and Huang, S.J., Mechanism of the biodegradation of polycaprolactone. Polym. Prep., 24 (1) (1983) 32-33.
19. Klang, S., Frucht-Pery, J., Hoffman, A. and Benita, S., Physicochemical characterization and acute toxicity evaluation of a positively charged submicron emulsion vehicle. J. Pharm. Pharmacol., 46 (1994) 986-993.
20. Leray, A.M., Vert, M., Gautier, J.C. and Benoit, J.P., End-chain radiolabeling and in vitro stability studies of radiolabeled poly(hydroxy acid) nanoparticles. J. Pharm. Sci., 83 (6) (1994) 845-851.
21. Li, S.M., Garreau, M. and Vert, M., Structure-property relationships in the case of the degradation of massive aliphatic poly (α-hydroxy acids) in aqueous media. Part 1: poly (D,L lactic acid). J. Mater Sci.: Mater. Med., 1 (1990) 123-130.
22. Losa, C., Calvo, P., Castro, E., Vila-Jato, L. and Alonso, M.J., Improvement of ocular penetration of amikacin sulphate by association to poly (butylcyanoacrylate) nanoparticles. J. Pharm. Pharmacol., 43 (1991a) 548-552.
23. Losa, C., Vila-Jato, J.L. and Alonso, M.J., Mechanism of drug release from lipid polymeric nanocapsules and physicochemical stability. Proc. Int. Symp. Controlled Release Bioact. Mater., 18 (1991b) 680-681.
24. Makino, K., Arakawa, M. and Kondo, T., Preparation and in vitro degradation properties of polylactide microcapsules. Chem. Pharm. Bull., 33 (3) (1985) 195-201.
25. Marchal Heussler, L., Développement d'un nouveau collyre: les vecteurs colloïdaux polymériques biodégradables de nature matricielle et vesiculaire. Intérêt dans le traitement du glaucome par les β bloquants. Thesis, Mention sciences pharmaceutiques, Université de Nancy I, France, 1991.
26. Masson, V., Billardon, P., Fessi, H., Devissaguet, J.P. and Puisieux, F., Tolerance studies and pharmacokinetic evaluation of indomethacin-loaded nanocapsules in rabbit eyes. Proc. Int. Symp. Controlled Release Bioact. Mater., 19 (1992) 423-424.
27. Masson, V., Maurin, F., Fessi, H. and Devissaguet, J.P., Influence of sterilization processes on poly (ε caprolactone) nanospheres. Biomaterials, (submitted).
28. Müller, R., Lherm, C., Herbort, J. and Couvreur, P., In vitro model for the degradation of alkylcyanoacrylate nanoparticles. Biomaterials, 11 (1990) 590-595.
29. Niwa, T., Takeuchi, H., Hino, T., Kunou, N. and Kawashima, Y., In vitro drug release behavior of D,L-lactide/glycolide copolymer (PLGA) nanospheres with nafarelin acetate prepared by a novel spontaneous emulsification solvent diffusion method. J. Pharm. Sci., 83 (5) (1994) 727-732.
30. O'Hagan, D., Jeffery, H. and Davis, S., The preparation and characterization of poly (lactide-coglycolide) microparticles: III. Microparticle/polymer degradation rates and the in vitro release of a model protein. Int. J. Pharm., 103 (1994) 37-45.
31. O'Mullane, J., Petrak, K., Hutchinson, L. and Tomlinson, E., The effect of adsorbed coats of poloxamers 237 and 338 on the in vitro aggregation and in vivo distribution of polystyrene latex (PSL) particles. Int. J. Pharm., 63 (1990) 177-180.
32. Pilar Calvo, E., Vila-Jato, J. and Alonso, M.J., Unstabilization and stabilization of PECL nanoparticles by protein adsorption. Proc. Int. Symp. Controlled Release Bioact. Mater., 18 (1991) 278-279.
33. Pitt, C., Poly ε caprolactone and its copolymers. Drugs Pharm. Sci., 45 (1990) 71-120.
34. Pitt, C., Non-microbial degradation of polyesters: mechanisms and modifications. Spec. Publ. R. Soc. Chem., 109 (1992) 7-19.
35. Pitt, C. and Schindler, A., Capronor: a biodegradable delivery system for levonorgestrel. In Zotuchni, G. et al. (Eds), Long Acting Contraceptive Delivery Systems. Harper and Rao, Philadelphia, 1984, pp. 48-68.
36. Potts, J. and Clendinning, R., The biodegradability of synthetic polymers. In Grillet, J. (Ed), Polymers and Ecological Problems. Plenum Press, New York, 1973, pp. 61-79.
37. Rafler, G. and Jobmann, M., Controlled release systems of biodegradable polymers. 1st communication: hydrolytic degradation of biodegradable aliphatic polyesters. Pharm. Ind., 56 (6) (1994) 565-570.
38. Taylor, M.S., Daniels, A.U., Andriano, K.P. and Heller, J., Six bioabsorbable polymers: in vitro acute toxicity of accumulated degradation products. J. Appl. Biomater., 5 (1994) 151-157.
39. Tokiwa, Y., Ando, T., Suzuki, T. and Takeda, K., Biodegradation of synthetic polymers containing ester bonds. ACS Symp. Ser., 433 (1990) 136-148.
40. Valero, J., Estabilidad de sistemas polimericos nanoparticulares biodegradables. Cienc. Pharm., 3 (2) (1993) 75-80.
41. Vyas, S., Ramchandraiah, S., Jain, C. and Jain, S., Polymeric pseudolatices bearing pilocarpine for controlled ocular delivery. J. Microencaps., 9 (3) (1992) 347-355.
42. Wallis, K. and Müller, R., Comparative measurements of nanoparticle degradation velocity using an accelerated hydrolysis test. Pharm. Ind., 55 (2) (1993) 168-170.
43. Williams, D., Mechanisms of biodegradation of implantable polymers. Clin. Mater., 10 (1992) 9-12.
44. Zimmer, A., Mutschler, E., Lambrecht, G., Mayer, D. and Kreuter, J., Pharmacokinetic and pharmacodynamic aspects of an ophthalmic pilocarpine nanoparticle delivery system. Pharm. Res., 11 (10) (1994) 1435-1442.